(Reuters) – ICON Public Ltd Co said on Wednesday it is partnering with the U.S. government to execute a clinical trial to test the effectiveness of next generation COVID-19 vaccine candidates.
(Reporting by Pratik Jain in Bengaluru; Editing by Saumyadeb Chakrabarty)
